When was Phylos Bioscience founded?

Phylos Bioscience was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is Phylos Bioscience located?

Phylos Bioscience is headquartered in Portland, United States.

Who is the current CEO of Phylos Bioscience?

Mowgli Holmes of Phylos Bioscience.

How many employees does Phylos Bioscience have?

As of Apr 30, 2026, the latest employee count at Phylos Bioscience is 50.

Is Phylos Bioscience a funded company?

Phylos Bioscience is a funded company, having raised a total of $31.7M across 11 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 20, 2015.

When was the latest funding round of Phylos Bioscience?

Phylos Bioscience's latest funding was a $***** Series B round on Dec 31, 2025, with participation from 1 investor. Its primary sector is Forestry Tech. Globally, the Forestry Tech sector has seen $10.7M in funding in 2026 to date.

Where does Phylos Bioscience rank among its competitors?

Phylos Bioscience ranks 5th amongst 436 active competitors, of which 97 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Tropic Biosciences, which secured $105M in Mar, 2026.

Who are the top competitors of Phylos Bioscience?

Phylos Bioscience's top competitors include Advanta, Tropic Biosciences and Pairwise. Among them, Tropic Biosciences secured the most recent funding round in March, 2026.

Phylos Bioscience - 2026 Company Profile, Team, Funding & Competitors

Phylos Bioscience is a series B company based in Portland (United States), founded in 2014 by Nishan Karassik and Mowgli Holmes. It operates as a Developer of cannabis F1 hybrid seeds and natural THC products. Phylos Bioscience has raised $31.7M in funding from Merida Capital Partners. The company has 436 active competitors, including 97 funded and 65 that have exited. Its top competitors include companies like Advanta, Tropic Biosciences and Pairwise.

Company Details

Developer of cannabis F1 hybrid seeds and natural THC products. The company empowers growers to produce high-quality cannabis cost-effectively. It offers elite, phenotypically-stable, fully-feminized true F1 hybrid seed lines. The company's seed-grown plants rival the uniformity of clonal varieties for harvest height, wet biomass, and total THC. It provides insights on mitigating HLVd risk with F1 hybrid production-ready seeds.

Website: phylos.bio
Social
Email ID: *****@phylos.bio
Phone Number: +1 **********

Key Metrics

Founded Year

2014

Location

Portland, United States

Stage

Series B

Total Funding

$31.7M in 11 rounds

Latest Funding Round

Series B, Dec 31, 2025, $*****

Investors

Merida Capital Partners & 7 more

Ranked

5^th among 436 active competitors

Employee Count

50 as on Apr 30, 2026

Similar Companies

Advanta & 309 more

View Phylos Bioscience's full profile

Phylos Bioscience is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Phylos Bioscience, Inc. CIN: 46-4844470 , United States, Active	Feb 23, 2017	-	61 (As on Dec 31, 2020)	-

Phylos Bioscience has raised a total funding of $31.7M over 11 rounds. Its first funding round was on Jan 20, 2015. Its latest funding round was a Series B round on Dec 31, 2025 for $*****. 1 investor participated in its latest round. Phylos Bioscience has 8 institutional investors.

Here is the list of recent funding rounds of Phylos Bioscience:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 31, 2025	1539326	Series B	9444627	5890659	1585317	1136746
Dec 09, 2025	6805672	Series B	5613168	5352843	1922306	9994104
Oct 15, 2024	4729071	Series B	2950153	4529494	4677842	6717630

Access funding benchmarks and valuations. Sign up today!

View details of Phylos Bioscience's funding rounds and investors

The founders of Phylos Bioscience are Nishan Karassik and Mowgli Holmes.

Here are the details of Phylos Bioscience's key team members:

Nishan Karassik: Chief Innovation Officer, Founder of Phylos Bioscience.
Mowgli Holmes: Co-Founder & CEO of Phylos Bioscience.

View details of Phylos Bioscience's Founder profiles and Board Members

Phylos Bioscience's employee count trend

Phylos Bioscience has 50 employees as of Apr 26. Here is Phylos Bioscience's employee count trend over the years:

Employee count trend for Phylos Bioscience

Uncover Phylos Bioscience's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Phylos Bioscience include Advanta, Tropic Biosciences and Pairwise. Here is the list of Top 10 competitors of Phylos Bioscience, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Advanta 1989, Dubai (United Arab Emirates), Public	Developer of high-nutrition crops for sustainable agriculture	$400M	KKR, United States Department of Agriculture ... & 5 others	70/100
2nd	Tropic Biosciences 2016, Norwich (United Kingdom), Series C	Developer of gene editing technologies for improved tropical crop production	$179M	Aliment Capital, ADQ & 39 others	68/100
3rd	Pairwise 2017, Durham (United States), Series C	Provider of gene editing technology for climate-resilient, nutritious, and sustainable crops	$155M	Deerfield, Aliment Capital & 5 others	64/100
4th	Cibus 2001, San Diego (United States), Public	Developer of precision breeding technologies for resilient and vigorous crops	$34.5M	Qubis, Fidelity Investments & 7 others	62/100
5th	Phylos Bioscience 2014, Portland (United States), Series B	Developer of cannabis F1 hybrid seeds and natural THC products	$31.7M	V. Gastevich Investments, Arcadian Capital ... & 6 others	60/100
6th	Nuziveedu Seeds 1973, Hyderabad (India), Late Stage	Provider of breeding programs that genetically enhance crops for substantial gains	$105M	Blackstone, BIRAC & 9 others	59/100
7th	Evogene 2002, Rehovot (Israel), Public	Developer of computational tools for pharmaceutical and agricultural industries	-	Hunza Ventures, Rhodium & 4 others	58/100
8th	Renaissance BioScience 2013, Vancouver (Canada), Series A	Developer of bioengineering technology for agriculture, food, health, and industrial markets	$5M	Cfin-Rcia, Carpere Capital Management & 2 others	57/100
9th	Ohalo 2019, Aptos (United States), Series C	Developer of plant breeding systems for potatoes, almonds, and strawberries	$40M	-	57/100
10th	Biographica 2022, London (United Kingdom), Seed	Computational Platform for gene discovery and editing	$9.5M	Faber, SuperSeed & 4 others	56/100